0 5

Cited 0 times in

Cited 0 times in

Preliminary results of pravastatin on non-hemorrhagic vertebral artery dissection: an exploratory randomized and controlled study

Authors
 Hyun Jin Han  ;  Keun Young Park  ;  Chang Ki Jang  ;  Joonho Chung  ;  Yong Bae Kim  ;  Sung Ho Lee  ;  Kangmin Kim  ;  Hyun-Seung Kang  ;  Jeong Eun Kim  ;  Won-Sang Cho 
Citation
 BMC NEUROLOGY, Vol.25(1) : 241, 2025-06 
Journal Title
BMC NEUROLOGY
Issue Date
2025-06
Keywords
Magnetic resonance imaging ; Pilot study ; Pleiotropic effects ; Pravastatin ; Vertebral artery dissection
Abstract
Background: There is limited information about the pleiotropic effects of statin on cerebrovascular diseases. The authors aimed to investigate the effect of pravastatin on non-hemorrhagic vertebral artery dissection (VAD) in a clinical setting.

Methods: An exploratory randomized and controlled study was designed for the non-hemorrhage VAD (CRIS, KCT00035970). Primary outcomes were 1- and 6-month radiologic changes on vessel wall magnetic resonance imaging (VW-MRI), with secondary outcomes related to the clinical and laboratory parameters, and safety outcomes of the pravastatin use.

Results: Finally, 23 patients were enrolled, consisting of 12 in the pravastatin group and 11 in the control with similar baseline characteristics except the age (55.0 versus 45.5 years, P = .01). Morphologic changes in the early period (0–1 month) were more improved or resolved in the pravastatin group with a borderline significance (crude odds ratio: 7.500 [95% confidence interval: 0.921-64.047], P = .06). However, age-adjusted analysis showed no difference in morphologic changes between the groups (adjusted odds ratio: 0.853 [95% confidence interval: 0.033-22.020], P = .92). The serum level of high-sensitivity C-reactive protein (hs-CRP) in the pravastatin group showed a descending tendency in the early period (Z-score: -1.843, P = .07), whereas it significantly increased in the control (Z-score: -2.371, P = .02). There were no safety issues at all.

Conclusion: Pravastatin had a borderline significant effect on the recovery of non-hemorrhage VAD with no additional adverse effects. A further study with a larger scale is expected to make more concrete evidences about the pleiotropic effects of statin on the non-hemorrhagic VAD.

Trial registration: The present study registered in a clinical research information service approved by World Health Organization (CRIS, KCT00035970, Registered on 7 March 2019; available at: https://cris.nih.go.kr/cris/search/detailSearch.do?seq=25234%26status=5%26seq_group=12949%26search_page=M).

Supplementary Information: The online version contains supplementary material available at 10.1186/s12883-025-04257-7.
Files in This Item:
T202506024.pdf Download
DOI
10.1186/s12883-025-04257-7
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Neurosurgery (신경외과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Yong Bae(김용배) ORCID logo https://orcid.org/0000-0003-2262-7157
Park, Keun Young(박근영)
Jang, Chang Ki(장창기) ORCID logo https://orcid.org/0000-0001-8715-8844
Chung, Joon Ho(정준호)
Han, Hyun Jin(한현진) ORCID logo https://orcid.org/0000-0002-4111-4819
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/207635
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links